NIH Intramural Research Program manages a list of intramural immunologists.
The IIG committee has created an expanded the list of immunologists at NIH and included IIG member immunologists from the Food and Drug Administration (FDA).
Members are listed by last name. Jump to the correct letter using these links:
The IIG sponsors activities that are crucial to fostering interactions and promoting scientific communication among the NIH-FDA Immunology Community:
All Immunology Interest Group (IIG) activities are organized by the Steering Committee, whose members (that comprise senior investigators, tenure track investigators, staff scientists, postdoctoral fellows and graduate students) are elected annually by the entire IIG community.
* new committee members
The NIH-FDA Immunology Interest Group (IIG) organizes activities designed to promote information exchange and interactions among NIH and FDA scientists interested in the field of immunology. Interactions are facilitated via weekly meetings on current topics as well as an Annual Immunology Workshop. The IIG of the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) is a voluntary organization of investigators and trainees who are members of the intramural research community of the NIH, FDA, and affiliated research and teaching organizations that promotes the mission of the NIH and FDA in research and training in the areas of immunology and infectious diseases. The IIG serves as the organizational structure for intramural researchers to promote high academic standards of research and training and foster the development of new biomedical knowledge and the translation of research knowledge into new preventive measures and therapies for human diseases by facilitating interdisciplinary and multidisciplinary research. The IIG was instituted in 1993. The IIG is the largest interest group on campus with over 500 active members in 19 different institutes and over 1000 subscribers to the list-serve.
The IIG sponsors two primary activities that are crucial to fostering interactions and promoting scientific communication among the NIH-FDA Immunology Community:
All IIG activities are organized by the Steering Committee, whose members are elected annually by the entire IIG community. Steering Committee members comprise senior investigators, tenure track investigators, Staff scientists, Postdoctoral fellows and graduate students. See the current IIG Steering Committee members.
To join or leave the IIG listserv, IMMUNI-L, follow the instructions on the NIH Listserv. For the listserv, you must use the same email address that is listed in the NIH Enterprise Directory.
Scanning electron micrograph of methicillin-resistant Staphylococcus aureus and a dead human neutrophil.
The NIH-FDA Immunology Interest Group (IIG) organizes activities designed to promote information exchange and interactions among NIH and FDA scientists interested in the field of immunology. Interactions are facilitated via weekly meetings on current topics as well as an Annual Immunology Workshop.
NIH Intramural Research Program manages a list of intramural immunologists.
The IIG committee has created an expanded the list of immunologists at NIH and included IIG member immunologists from the Food and Drug Administration (FDA).
NIH published this notice of funding opportunity (NOFO) in a September 9, 2022 Guide announcement.
Updated May 28, 2021. NIH posted the “When should I reach out to NIAID staff if I am considering submitting a P01 application?” shown below.
Jenna Bergerson, M.D. is an assistant research physician at NIAID. She has been involved in translational research in primary immune deficiencies and disorders of immune dysregulation since joining the Primary Immune Deficiency Clinic in 2017.
She received her M.D. from Tulane University School of Medicine. She completed a pediatric residency at Rainbow Babies & Children’s Hospital, Case Western University Medical Center in Cleveland, OH, followed by a fellowship in allergy and immunology at The Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Medical Center. She also holds a master of public health degree from Tulane University School of Public Health. She is board certified in pediatrics and allergy-immunology and is a fellow of the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the Clinical Immunology Society (CIS).
At NIH, she serves as the co-director of the Allergy-Immunology Consult Service, as the Deputy Director of the Primary Immune Deficiency Clinic, and on the NIAID inpatient-outpatient working group committee. Her external committee activities include involvement in the membership committee of the Clinical Immunology Society.
Dr. Bergerson’s current research and clinical activities focus on seeing patients with a wide variety of primary immune deficiency disorders and primary disorders of immune dysregulation.
Hsu AP, Donkó A, Arrington ME, Swamydas M, Fink D, Das A, Escobedo O, Bonagura V, Szabolcs P, Steinberg HN, Bergerson J, Skoskiewicz A, Makhija M, Davis J, Foruraghi L, Palmer C, Fuleihan RL, Church JA, Bhandoola A, Lionakis MS, Campbell S, Leto TL, Kuhns DB, Holland SM. Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects. Blood. 2019 May 2;133(18):1977-1988.
Bergerson JRE, Freeman AF. An Update on Syndromes with a Hyper-IgE Phenotype. Immunol Allergy Clin North Am. 2019 Feb;39(1):49-61. doi: 10.1016/j.iac.2018.08.007. Review. PMID:30466772
Arts K, Bergerson JRE, Ombrello AK, Similuk M, Oler AJ, Agharahimi A, Mace EM, Hershfield M, Wouters C, De Somer L, Morren MA, Diego RP, Moens L, Freeman AF, Meyts I. Warts and DADA2: a Mere Coincidence? J Clin Immunol. 2018 Nov;38(8):836-843.
Jhamnani RD, Nunes-Santos CJ, Bergerson J, Rosenzweig SD. Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects. Front Immunol. 2018 Sep 26;9:2172.
Gupta M, Aluri J, Desai M, Lokeshwar M, Taur P, Lenardo M, Bergerson J, Dalvi A, Mhatre S, Kulkarni M, Kambli P, Madkaikar M. Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India. Front Immunol. 2018 Jun 14;9:1049.
Khanolkar A, Kirschmann DA, Caparelli EA, Wilks JD, Cerullo JM, Bergerson JRE, Jennings LJ, Fuleihan RL. CD4 T cell-restricted IL-2 signaling defect in a patient with a novel IFNGR1 deficiency. J Allergy Clin Immunol. 2018 Jan;141(1):435-439.e7.
Allergy and Immunology
Dr. Bergerson’s current research and clinical activities focus on seeing patients with a wide variety of primary immune deficiency disorders and primary disorders of immune dysregulation.
James AE, West L, Schloss K, Nataraj P, Urban A, Hirsch A, Krausz M, Kumar S, Raasch J, Risma K, Church JA, Grimbacher B, Bergerson JRE, Chong H, Freeman AF. Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation. J Allergy Clin Immunol Pract. 2022 May;10(5):1367-1370.e1.
Nunes-Santos CJ, Koh C, Rai A, Sacco K, Marciano BE, Kleiner DE, Marko J, Bergerson JRE, Stack M, Rivera MM, Constantine G, Strober W, Uzel G, Fuss IJ, Notarangelo LD, Holland SM, Rosenzweig SD, Heller T. Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication. J Allergy Clin Immunol. 2022 Jan;149(1):400-409.e3.
Delmonte OM, Bergerson JRE, Burbelo PD, Durkee-Shock JR, Dobbs K, Bosticardo M, Keller MD, McDermott DH, Rao VK, Dimitrova D, Quiros-Roldan E, Imberti L, Ferrè EMN, Schmitt M, Lafeer C, Pfister J, Shaw D, Draper D, Truong M, Ulrick J, DiMaggio T, Urban A, Holland SM, Lionakis MS, Cohen JI, Ricotta EE, Notarangelo LD, Freeman AF. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity. J Allergy Clin Immunol. 2021 Nov;148(5):1192-1197.
Delmonte OM, Bergerson JRE, Kawai T, Kuehn HS, McDermott DH, Cortese I, Zimmermann MT, Dobbs AK, Bosticardo M, Fink D, Majumdar S, Palterer B, Pala F, Dsouza NR, Pouzolles M, Taylor N, Calvo KR, Daley SR, Velez D, Agharahimi A, Myint-Hpu K, Dropulic LK, Lyons JJ, Holland SM, Freeman AF, Ghosh R, Similuk MB, Niemela JE, Stoddard J, Kuhns DB, Urrutia R, Rosenzweig SD, Walkiewicz MA, Murphy PM, Notarangelo LD. SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation. Blood. 2021 Sep 23;138(12):1019-1033.
Hsu AP, Donkó A, Arrington ME, Swamydas M, Fink D, Das A, Escobedo O, Bonagura V, Szabolcs P, Steinberg HN, Bergerson J, Skoskiewicz A, Makhija M, Davis J, Foruraghi L, Palmer C, Fuleihan RL, Church JA, Bhandoola A, Lionakis MS, Campbell S, Leto TL, Kuhns DB, Holland SM. Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects. Blood. 2019 May 2;133(18):1977-1988.
Arts K, Bergerson JRE, Ombrello AK, Similuk M, Oler AJ, Agharahimi A, Mace EM, Hershfield M, Wouters C, De Somer L, Morren MA, Diego RP, Moens L, Freeman AF, Meyts I. Warts and DADA2: a Mere Coincidence? J Clin Immunol. 2018 Nov;38(8):836-843
Allergy and Immunology Fellowship Program
NIAID offers a three-year training program in allergy and immunology. This program, open to physicians who have completed internal medicine and/or pediatric residency training, is designed to provide trainees with high-quality clinical and research skills that will enable them to successfully pursue careers in academic medicine.
The NIAID Allergy and Immunology Clinical Fellowship Program is fully accredited by the Accreditation Council for Graduate Medical Education (ACGME). Fellows are eligible to sit for the Board of Allergy and Immunology certification examination after successful completion of the first two years of the program.
A cooperative agreement (U) is a support mechanism we frequently use for high-priority research areas that require substantial involvement from NIH program or scientific staff.
Over twenty years, Dr. Lehmann has studied the population genetics, ecology, and behavior of the African malaria mosquito, Anopheles gambiae, and its relationship to disease transmission and control. As a postdoc, under Frank Collins at CDC, he studied patterns of gene flow among populations of this species and the degree of isolation between sibling species on the genetic level. This led to studies on the behavioral and ecological mechanisms that promote reproductive isolation (speciation) between diverging populations. In addition, he was tempted again and again to study the factors and processes that determine susceptibility of mosquitoes to pathogen. Over the past ten years, his obsession has been to resolve the “dry season malaria paradox” and uncover how mosquitoes persist through the long dry season without available surface water as larval sites. Studies he has led have produced compelling evidence for aestivation (summer dormancy) and long-distance migration in the persistence of vectors and malaria in dry areas. Before joining NIH, Dr. Lehmann studied the molecular epidemiology of toxoplasmosis, the behavior of the parasitic nematodes in the body of their blackfly host, and the population biology of ectoparasites on rodent hosts.
As part of the Mosquito Ecology research program, we explore broad population biology questions relevant to patterns of malaria transmission and vector control. We are studying the ecology of mosquitoes, addressing questions relevant to patterns of malaria transmission and vector control. Together with colleagues in Mali and elsewhere, we investigate the role of dormancy and long-range migration in the persistence of mosquitoes and malaria in seasonally arid areas, the processes affecting spread of genes within and between populations, and vector-parasite interactions at the population level. The nature of these topics within the One Health paradigm demands novel and creative approaches to answer stubborn old questions and identify new ones. Thus, we combine ecological, behavioral, physiological, genetic, and molecular analyses grounded in field studies to improve understanding of phenotypic diversity in vectors and its epidemiological consequences. The research group is nested in the Malaria Culture and Insectary Unit/Office of the Chief, LMVR, under Dr. Thomas Wellems.
Dr. Adama Dao (MRTC, Mali), Dr. Alpha S. Yaro (MRTC, Mali), Dr. Roy Faiman (LMVR), Dr. Ben Krajacich (LMVR), Mr. Moussa Diallo (MRTC, Mali), Mrs. Margie Sullivan, Mr. Zana L. Sanogo (MRTC, Mali), Dr. Djibril Samake (MRTC, Mali)
Huestis DL, Dao A, Diallo M, Sanogo ZL, Samake D, Yaro AS, Ousman Y, Linton Y-M, Krishna A, Veru L, Krajacich BJ, Faiman R, Florio J, Chapman JW, Reynolds DR, Weetman D, Mitchell R, Donnelly MJ, Talamas E, Chamorro L, Strobach E and Lehmann T. Windborne long-distance migration of malaria mosquitoes in the Sahel. Nature: In Press.
Dharmarajan G, Walker KD, Lehmann T. Variation in tolerance to parasites affects vectorial capacity of natural Asian tiger mosquito populations. Current Biology: In Press.
Faiman R, Dao A, Yaro AS, Diallo M, Djibril S, Sanogo ZL, Ousmane Y, Sullivan M, Veru L, Krajacic BJ, Krishna A, Matthews J, France CAM, Hamer G, Hobson KA, Lehmann T. Marking mosquitoes in their natural larval sites using 2H‐enriched water: A promising approach for tracking over extended temporal and spatial scales. Methods Ecol Evol. 2019 May 17;10(8):1274-85.
Dao A, Yaro AS, Diallo M, Timbiné S, Huestis DL, Kassogué Y, Traoré AI, Sanogo ZL, Samake D, Lehmann T. Signatures of aestivation and migration in Sahelian malaria mosquito populations. Nature. 2014 Dec 18;516(7531):387-90.
Diabate Abdoulaye, Dabire K Roch, Heidenberger Kyle, Crawford Jacob, William Lamp, Culler Lauren, Lehmann Tovi. Evidence for divergent selection between the molecular forms of Anopheles gambiae: role of predation. BMC Evol Biol. 2008 Jan 11;8:5.
Lehmann T, Licht M, Elissa E, Maega BTA, Chimumbwa JM Watsenga FT, Wondji CS, Simard F, Hawley WA. Population Structure of Anopheles gambiae in Africa. J Hered. 2003 Mar-Apr;94(2):133-47.
LMVR Insectaries (including secured area)
As part of the Mosquito Ecology research program, we explore broad population biology questions relevant to patterns of disease transmission and vector control.. Together with colleagues in Mali and elsewhere, we investigate the role of dormancy and long-range windborne migration in the persistence of mosquitoes and malaria in seasonally arid areas, the processes affecting spread of genes within and between populations, and vector-parasite interactions at the population level. The nature of these topics within the One Health paradigm demands novel and creative approaches to answer stubborn old questions and identify new ones. We combine ecological, behavioral, physiological, genetic, and molecular analyses grounded in field studies to improve understanding of phenotypic diversity in vectors and its epidemiological consequences. The research group is nested in the Office of the Chief, LMVR, under Dr. Barillas-Mury.
Faiman F, Yaro AS,Dao A, Sanogo ZL, Diallo M, Samake D, Yossi O, Veru LR, Graber LC, Conte AR, Kouam C, Krajacich BJ, Lehmann T. Isotopic evidence that aestivation allows malaria mosquitoes to persist through the dry season in the Sahel. Nature Ecology & Evolution 2022: In Press.
Dharmarajan G, Walker KD, Lehmann T. Variation in Tolerance to Parasites Affects Vectorial Capacity of Natural Asian Tiger Mosquito Populations v. Curr Biol. 2019 Nov 18;29(22):3946-3952.e5.
Huestis DL, Dao A, Diallo M, Sanogo ZL, Samake D, Yaro AS, Ousman Y, Linton YM, Krishna A, Veru L, Krajacich BJ, Faiman R, Florio J, Chapman JW, Reynolds DR, Weetman D, Mitchell R, Donnelly MJ, Talamas E, Chamorro L, Strobach E, Lehmann T. Windborne long-distance migration of malaria mosquitoes in the Sahel v. Nature. 2019 Oct;574(7778):404-408.
Dao A, Yaro AS, Diallo M, Timbiné S, Huestis DL, Kassogué Y, Traoré AI, Sanogo ZL, Samake D, Lehmann T. Signatures of aestivation and migration in Sahelian malaria mosquito populations. Nature. 2014 Dec 18;516(7531):387-90. *
Diabate Abdoulaye, Dabire K Roch, Heidenberger Kyle, Crawford Jacob, William Lamp, Culler Lauren, Lehmann Tovi. Evidence for divergent selection between the molecular forms of Anopheles gambiae: role of predation. BMC Evol Biol. 2008 Jan 11;8:5.
Lehmann T, Licht M, Elissa E, Maega BTA, Chimumbwa JM Watsenga FT, Wondji CS, Simard F, Hawley WA. Population Structure of Anopheles gambiae in Africa. J Hered. 2003 Mar-Apr;94(2):133-47.
Dr. Adama Dao (MRTC, Mali), Dr. Alpha S. Yaro (MRTC, Mali), Dr. Roy Faiman (LMVR), Dr. Ben Krajacich (LMVR), Mr. Moussa Diallo (MRTC, Mali), Mrs. Margie Sullivan, Mr. Zana L. Sanogo (MRTC, Mali), Dr. Djibril Samake (MRTC, Mali)
LMVR Insectaries (including secured area)
Malaria control: The great mosquito hunt
Mosquitoes may surf winds above Africa more than we realized
Life-Long Mosquito Marking: Are Stable Isotopes the Key?
The Anopheles gambiae 1000 Genomes Consortium
Monitoring Windborne Migration of Disease Vectors, Pathogens, and Pests in Africa to Improve Public Health and Food Security (MWMDVPPiA)